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Left Atrial Appendectomy and Maze
The feasibility and effectiveness of specific linear left atrial (LA)
lesions to treat atrial fibrillation (AF) were addressed by Kottkamp
et al. (1) in a recent issue of the Journal. Interestingly, linear lesions
confined to the left atrium were able to cure AF in more than 90%
of cases, and the technique was feasible with a minimally invasive
right mini-thoracotomy approach. Although the main objective of
AF cure is the restoration of sinus rhythm, it should be emphasized
that the most dreadful consequence of the disease is embolic
cerebrovascular accidents (CVA). Atrial fibrillation is responsible
for 20% of all strokes, and the risk of stroke is increased fivefold in
nonrheumatic AF and 17-fold in patients with mitral stenosis and
AF (2).
The efficacy of systemic anticoagulation with warfarin to reduce
the incidence of stroke has been demonstrated in randomized
clinical trials, and the left atrial appendage (LAA) has been
recognized as the source of more than 90% of emboli leading to
CVA (3,4). Fifty percent of AF patients are age 75 or older, and
it has been estimated that at least 20% have a contraindication to
warfarin treatment (5). We believe that the importance of the
LAA in the generation of embolic strokes should be addressed
when a surgical approach to AF is contemplated and, therefore, we
are concerned that the procedure proposed by Kottkamp et al. (1)
may result in higher rate of CVA as compared to the classic maze
approach, which includes LA appendectomy (6,7). It has been
demonstrated that the maze procedure is associated with three-
year 100% freedom from thromboembolic complications as com-
pared to 83% in the non-maze group (8). In the study by
Kottkamp et al. (1) surgical ablation was associated with restora-
tion of sinus rhythm and an increase in LAA flow velocity that
could potentially release occult clots into the systemic circulation.
Moreover, oral anticoagulant therapy was prescribed for at least 3
months, the mean follow-up limited to 18 months and the
incidence of CVA not mentioned.
Consequently, we would like the investigators to share their
long-term results on freedom from thromboembolism associated
with the innovative approach proposed. A minimally invasive
method for removing and/or occluding the LAA would provide a
valuable strategy for preventing stroke in patients with AF. Both
percutaneous LAA occlusion and thoracoscopic LAA amputation
have been recently developed, although further studies are needed
to confirm the safety and efficacy of these approaches (7,9).
Additional investigation is needed to determine whether LAA
obliteration, which might have a potential clinical impact similar to
carotid endarterectomy, is effective in preventing thromboembo-
lism and whether it can be advocated as a “must” in the treatment
of a selected population of patients with AF.
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REPLY
We would like to thank Dr. Bonanomi and colleagues for their
interest in our work and for their thorough comments. The
spectrum of patients with atrial fibrillation (AF) is very wide and
varies from the 35-year-old manager with recurrent weekly parox-
ysms of AF resistant to antiarrhythmic drugs and severe symptoms
to the 75-year-old man with hypertension and concomitant
asymptomatic rate-controlled AF. Effective and safe treatment
strategies are available for many patients, and these often consist of
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beta-blockers for rate control plus oral anticoagulation for preven-
tion of thromboembolic events. However, a uniformly effective and
safe treatment strategy for all patients with AF does not exist
owing to the diversity of patients with respect to symptoms, age,
underlying heart disease, responsiveness to drugs, and so on.
Curative treatment of AF with the potentiality for widespread
clinical application remains one of the main challenges of inter-
ventional electrophysiology. Given the complex electrophysiologic
nature of AF, interventional treatment strategies target at patho-
physiologic cornerstones of AF (i.e., the initiating or the main-
taining factors). Surgical series from Cox et al. (1) and others as
well as catheter ablation studies from Haissaguerre et al. (2) and
others have all substantially contributed to both the understanding
of the pathophysiology of AF and the development of clinical
treatment strategies for our patients. In our recently published
study (3), a new specific concept of intraoperative radiofrequency
ablation was described. Dr. Bonanomi and Colleagues addressed
the important question of thromboembolic events. In our pub-
lished series of 70 patients with AF, normalized left atrial
mechanical transport function could be documented in all patients
with postoperative sinus rhythm during follow-up, and no throm-
boembolic complications were observed (3). Clearly, larger patient
cohorts and longer follow-up periods in studies specifically ad-
dressing the incidence of thromboembolic complications and the
role of oral anticoagulation after interventional treatment of AF
will be necessary to clarify this issue.
Finally, Dr. Bonanomi and colleagues also mentioned prelimi-
nary reports on percutaneous occlusion and thoracoscopic ampu-
tation of the left atrial appendage. Again, all these clinical studies
contribute to the puzzle. We are convinced, however, that the
future gold standard of interventional treatment of AF will restore
sinus rhythm with normalized atrial mechanical function.
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